相关实验视频

Updated: Jun 28, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

单元管道感染治疗:何时使用哪些药物,包括β-乳组合药物药物

Arsheena Yassin¹, Keith S Kaye², Tanaya Bhowmick³

¹Department of Pharmacy, Robert Wood Johnson University Hospital, 1 Robert Wood Johnson Place, New Brunswick, NJ 08901, USA.

Infectious disease clinics of North America

|April 9, 2024

概括

本综述涵盖了尿路感染 (UTI) 的抗生素治疗,包括那些由难以治疗的耐药细菌引起的. 它为有效管理常见和复杂的尿路感染提供了指导.

科学领域:

传染性疾病传染性疾病
药理学药理学是指药理学的学科.
泌尿器科泌尿器科泌尿器科泌尿器科

背景情况:

尿路感染 (UTI) 是一种常见的细菌感染,需要有效的抗生素治疗.
抗微生物耐药性的增加在治疗尿路感染方面带来了重大挑战.
特定的抗药性病原体,如VRE,产生ESBL的肠杆菌和耐卡巴胺菌株是新兴的威胁.

研究的目的:

审查目前针对急性无并发性和并发性尿路感染 (UTI) 的抗生素治疗选择.
检查由普遍存在的耐药病原体引起的尿路感染的治疗方案.
为临床医生管理具有挑战性的尿路感染病例提供最新的资源.

主要方法:

对尿路感染抗生素治疗策略的综合文献综述.
对治疗指南和临床研究进行分析,重点关注耐药病原体.
在各种尿路感染情景中综合关于抗生素有效性和适当使用的数据.

主要成果:

介绍了无并发性和复杂性尿路感染的确立抗生素选择.
讨论了对抗万胺素耐药性肠球菌 (VRE),扩展光谱β-乳糖酶 (ESBL) 产生的肠球菌,以及抗卡巴胺的肠球菌和伪杆菌引起的感染的管理方案.
该审查强调了考虑抗菌素敏感性的日益重要.

结论:

适当的抗生素选择对于成功治疗尿路感染至关重要.
由耐药生物体引起的尿路感染的管理需要专门的知识和量身定制的治疗方法.
本综述是优化抗生素使用的指南,在不断变化的尿路感染抗菌素耐药性领域.

关键词:

抗微生物耐药性抗微生物耐药性皮叶龙炎是一种炎症.尿路感染尿路感染

更多相关视频

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Drug Elimination by Renal Route: Tubular Secretion

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Tonsillitis II: Management

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.